NEUROCRINE BIOSCIENCES INC
CIK 914475 · last filed 2023-02-24
NEUROCRINE BIOSCIENCES INC is a corporate insider who has filed 2 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing shows the insider bought $39.0M of VYGR on Feb 24, 2023. Across all open-market trades the lifetime net is +$89.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $32.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$32.46M
1
2
$89.03M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYGR | 10%+ Owner | 8,575,316 | $3.79 | $32.46M | $89.03M | 2 | 2023-02-24 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-24 | VYGR | Buy (P) | +4,395,588 | $39.03M | EDGAR |
| 2019-03-14 | VYGR | Buy (P) | +4,179,728 | $50.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.